Who is sponsoring NCT04292418?

NCT04292418 is sponsored by Assiut University.

What drugs are being tested in NCT04292418?

Interventions in NCT04292418: Tacrolimus capsule , mycophenolic acid.

What condition does NCT04292418 study?

NCT04292418 studies Rejection Acute Renal.

Is NCT04292418 still recruiting?

NCT04292418 is currently status unknown. Last updated 3 March 2020.

Last reviewed 2020-03-03 · How we verify

NCT04292418

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictors of Rejection in Pediatric Kidney Transplantation

Status unknown Last updated 3 March 2020

What this trial tests

trial testing Tacrolimus capsule , mycophenolic acid in Rejection Acute Renal in 70 participants. Status unknown.

Timeline

1 May 2020

Primary endpoint
1 May 2020

1 October 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 May 2020
Primary completion	1 May 2020
Estimated completion	1 October 2021

Drugs / interventions tested

Tacrolimus capsule , mycophenolic acid — full drug profile →

Conditions studied

Rejection Acute Renal — all drugs for Rejection Acute Renal →

Sponsor

Assiut University

Who can join

Adults 4 to 18, any sex, with Rejection Acute Renal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Renal transplantation is the best option among the end-stage renal disease (ESRD) treatment alternatives, It is also relatively less expensive than dialysis. Allograft rejection is a major issue in kidney transplantation. Rejection is classified as acute or chronic, cellular or antibody-mediated.Children with kidney transplants require life-long immunosuppressive therapy to prevent rejection of the allograft

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04292418 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 3 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04292418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing